Cytosorbents Corp. (CTSO) is a publicly traded Healthcare sector company. As of September 5, 2026, CTSO trades at $0.34 with a market cap of $21.99M and a P/E ratio of -1.21. CTSO moved +3.43% today. Year to date, CTSO is -47.42%; over the trailing twelve months it is -63.74%. Its 52-week range spans $0.30 to $1.61. Analyst consensus is neutral with an average price target of $0.75. Rallies surfaces CTSO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for CTSO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.34 |
| Market Cap | $21.99M |
| P/E Ratio | -1.21 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $1.61 |
| 52-Week Low | $0.30 |
| Volume | 436.51K |
| Avg Volume | 0 |
| Revenue (TTM) | $37.22M |
| Net Income | $-18.21M |
| Gross Margin | 71.61% |
1 analysts cover CTSO: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.75.